These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 14513810

  • 21. Formulation development of an albendazole self-emulsifying drug delivery system (SEDDS) with enhanced systemic exposure.
    Meena AK, Sharma K, Kandaswamy M, Rajagopal S, Mullangi R.
    Acta Pharm; 2012 Dec; 62(4):563-80. PubMed ID: 24000442
    [Abstract] [Full Text] [Related]

  • 22. Body distribution of free, liposomal and nanoparticle-associated mitoxantrone in B16-melanoma-bearing mice.
    Reszka R, Beck P, Fichtner I, Hentschel M, Richter J, Kreuter J.
    J Pharmacol Exp Ther; 1997 Jan; 280(1):232-7. PubMed ID: 8996201
    [Abstract] [Full Text] [Related]

  • 23. Effect of surfactant on fabrication and characterization of paclitaxel-loaded polybutylcyanoacrylate nanoparticulate delivery systems.
    Mitra A, Lin S.
    J Pharm Pharmacol; 2003 Jul; 55(7):895-902. PubMed ID: 12906746
    [Abstract] [Full Text] [Related]

  • 24. Bioavailability comparison between albendazole and albendazole sulphoxide in rats and man.
    Dominguez L, Fagiolino P, Gordon S, Manta E.
    Farmaco; 1995 Oct; 50(10):697-702. PubMed ID: 8590577
    [Abstract] [Full Text] [Related]

  • 25. Cystic echinococcosis therapy: Albendazole-loaded lipid nanocapsules enhance the oral bioavailability and efficacy in experimentally infected mice.
    Pensel PE, Ullio Gamboa G, Fabbri J, Ceballos L, Sanchez Bruni S, Alvarez LI, Allemandi D, Benoit JP, Palma SD, Elissondo MC.
    Acta Trop; 2015 Dec; 152():185-194. PubMed ID: 26409727
    [Abstract] [Full Text] [Related]

  • 26. 5-amino salicylic acid bound nanoparticles for the therapy of inflammatory bowel disease.
    Pertuit D, Moulari B, Betz T, Nadaradjane A, Neumann D, Ismaïli L, Refouvelet B, Pellequer Y, Lamprecht A.
    J Control Release; 2007 Nov 20; 123(3):211-8. PubMed ID: 17889397
    [Abstract] [Full Text] [Related]

  • 27. [Study of biocompatibility of polybutylcyanoacrylate nanoparticles].
    Yang XX, Chen JH, Guo D.
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Oct 20; 25(10):1261-3. PubMed ID: 16234103
    [Abstract] [Full Text] [Related]

  • 28. Transport of Poly(n-butylcyano-acrylate) nanoparticles across the blood-brain barrier in vitro and their influence on barrier integrity.
    Rempe R, Cramer S, Hüwel S, Galla HJ.
    Biochem Biophys Res Commun; 2011 Mar 04; 406(1):64-9. PubMed ID: 21295549
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Evaluation of the interaction between ivermectin and albendazole following their combined use in lambs.
    Alvarez L, Lifschitz A, Entrocasso C, Manazza J, Mottier L, Borda B, Virkel G, Lanusse C.
    J Vet Pharmacol Ther; 2008 Jun 04; 31(3):230-9. PubMed ID: 18471144
    [Abstract] [Full Text] [Related]

  • 32. Intranasal microemulsion for targeted nose to brain delivery in neurocysticercosis: Role of docosahexaenoic acid.
    Shinde RL, Bharkad GP, Devarajan PV.
    Eur J Pharm Biopharm; 2015 Oct 04; 96():363-79. PubMed ID: 26318978
    [Abstract] [Full Text] [Related]

  • 33. [Study on mitoxantrone polycyanoacrylate nanospheres].
    Zhang ZR, Liao GT, Hou SX.
    Yao Xue Xue Bao; 1994 Oct 04; 29(7):544-9. PubMed ID: 7976360
    [Abstract] [Full Text] [Related]

  • 34. Preparation and characterization of sodium ferulate entrapped bovine serum albumin nanoparticles for liver targeting.
    Li FQ, Su H, Wang J, Liu JY, Zhu QG, Fei YB, Pan YH, Hu JH.
    Int J Pharm; 2008 Feb 12; 349(1-2):274-82. PubMed ID: 17870261
    [Abstract] [Full Text] [Related]

  • 35. Enhanced dissolution and systemic availability of albendazole formulated as solid dispersions.
    Castro SG, Sanchez Bruni SF, Urbizu LP, Confalonieri A, Ceballos L, Lanusse CE, Allemandi DA, Palma SD.
    Pharm Dev Technol; 2013 Feb 12; 18(2):434-42. PubMed ID: 22670782
    [Abstract] [Full Text] [Related]

  • 36. Lipidic matrix of albendazole: an alternative for systemic infections.
    Savio E, Domínguez L, Malanga A, Quevedo D, Saldaña J, Camarote C, Ochoa A, Fagiolino P.
    Boll Chim Farm; 1998 Oct 12; 137(9):345-9. PubMed ID: 9859596
    [Abstract] [Full Text] [Related]

  • 37. [The tissue distribution in mice and pharmacokinetics in rabbits of oridonin-solid lipid nanoparticles].
    Zhang DR, Ren TC, Lou HX, Xing J.
    Yao Xue Xue Bao; 2005 Jun 12; 40(6):573-6. PubMed ID: 16144328
    [Abstract] [Full Text] [Related]

  • 38. Comparative plasma disposition of fenbendazole, oxfendazole and albendazole in dogs.
    Gokbulut C, Bilgili A, Hanedan B, McKellar QA.
    Vet Parasitol; 2007 Sep 30; 148(3-4):279-87. PubMed ID: 17673370
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.